Glenmark to launch oral contraceptive drug in US soon
The company has received final approval for drospirenone and ethinyl estradiol tablet, a generic version of Bayer Healthcare Pharmaceuticals' Yaz tablet, from US FDA
"Glenmark Pharmaceuticals Inc, USA has been granted final approval by US FDA for drospirenone and ethinyl estradiol tablets USP, 3 mg/0.02 mg," the company said in a BSE filing on August 19, 2015.
According to IMS Health sales data, Yaz market achieved annual sales of approximately $170.1 million for the 12 months period ending June 2015.